Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils (Q43194459)

15 November 2017

title

Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils (English)

1 reference

15 November 2017

0 references

1 reference

1 reference

1 reference

1 reference

15 November 2017

1 reference

15 November 2017

H Wilms

1 reference

15 November 2017

P Rosenstiel

1 reference

15 November 2017

H Schäfer

1 reference

15 November 2017

D Seegert

1 reference

15 November 2017

P J Kahle

1 reference

15 November 2017

S Odoy

1 reference

15 November 2017

J H Claasen

1 reference

15 November 2017

C Holzknecht

1 reference

15 November 2017

L O Brandenburg

1 reference

15 November 2017

G Deuschl

1 reference

15 November 2017

S Schreiber

1 reference

15 November 2017

D Kirik

1 reference

15 November 2017

R Lucius

1 reference

15 November 2017

publication date

1 October 2009

1 reference

International Journal of Immunopathology and Pharmacology

15 November 2017

published in

1 reference

15 November 2017

1 reference

15 November 2017

1 reference

15 November 2017

page(s)

897-909

1 reference

Molecular pathogenesis of Parkinson disease

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Pathogenetic mechanisms of parkin in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Synuclein activates microglia in a model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Specific inhibition of c-Raf activity by semapimod induces clinical remission in severe Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

From theory to therapy: implications from an in vitro model of ramified microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Chemotactic-like receptors and Abeta peptide induced responses in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Internalization of PrP106-126 by the formyl-peptide-receptor-like-1 in glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Unique copper-induced oligomers mediate alpha-synuclein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

AChE-stained horizontal sections of the rat brain in stereotaxic coordinates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200405

10.1177/039463200902200405

21 January 2018

Identifiers

DOI

1 reference

15 November 2017

1 reference